The authors conclude that lorundrostat shows promise as an effective blood pressure–lowering therapy for patients with ...

Combination therapy with a nonsteroidal mineralocorticoid receptor antagonist and an SGLT2 inhibitor reduced albuminuria more ...

AstraZeneca unveiled its expanded, state-of-the-art manufacturing facility in Coppell, which will double the production of hyperkalemia treatment medication. AstraZeneca is a global science-led ...

With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the ...

Medical professional societies encourage development of treatment recommendations and/or guidelines that are based on current best evidence and represent a popular way of integrating evidence-based ...

Abstract: Wastewater treatment plants (WWTP), as common integrated energy systems (IES), efficiently manage electrical and thermal demands while utilizing renewable energy and biomass resources. This ...

An expert discusses how modern glaucoma treatment has evolved from a reactive one-size-fits-all approach of multiple drops followed by major surgery to a proactive, individualized strategy that ...

Among patients using RAASi for management of diabetes, heart failure, and chronic kidney disease, adjunctive SGLT2i was associated with lower hyperkalemia risk. Initiation of sodium-glucose ...

Researchers at the University of Cambridge developed an algorithm called PRRDetect that identifies tumors with faulty DNA repair systems, making them more likely to respond to treatments like ...

Reflecting the growing understanding of rosacea as a continuum of systemic inflammation, new National Rosacea Society (NRS) Treatment Algorithms suggest therapies based not on the rosacea subtype but ...